RPL9 and early-onset autosomal dominant Alzheimer disease: For RPL9 high expression, GSEA pathway scoring highlighted enrichment in Alzheimer disease, Huntington disease, oxidative phosphorylation, Parkinson disease, and ribosomes (Fig. 12C).